Literature DB >> 19211752

Human immunodeficiency virus integrates directly into naive resting CD4+ T cells but enters naive cells less efficiently than memory cells.

Jihong Dai1, Luis M Agosto, Clifford Baytop, Jianqing J Yu, Matthew J Pace, Megan K Liszewski, Una O'Doherty.   

Abstract

Resting CD4(+) T cells restrict human immunodeficiency virus (HIV) infection at or before reverse transcription, resulting in slower kinetics of reverse transcription. In a previous study, we showed that, despite this restriction at reverse transcription, HIV integration occurs in resting CD4(+) T cells, albeit with slower kinetics. In that study, the resting T cells were a mixture of memory and naïve cells. Here we asked whether the more quiescent naïve cell subset could be directly infected by HIV and, if so, whether the level of integration in naïve cells was comparable to that in memory cells. We found that HIV integrates in the naïve subset of resting CD4(+) T cells without prior activation of the cells. The level of integration (proviruses/cell) in naïve cells was lower than that in memory cells. This difference between naïve and memory cells was observed whether we inoculated the cells with R5 or X4 HIV and could not be explained solely by differences in coreceptor expression. The presence of endogenous dendritic cells did not change the number of proviruses/cell in memory or naïve cells, and deoxynucleoside pools were equally limiting. Our results instead indicate the existence of a novel restriction point in naïve T cells at viral fusion that results in reduced levels of fusion to naïve CD4(+) T cells. We conclude that HIV can integrate into both naïve and memory cells directly. Our data further support our hypothesis that integrated proviral infection of resting T cells can be established without T-cell activation.

Entities:  

Mesh:

Year:  2009        PMID: 19211752      PMCID: PMC2668451          DOI: 10.1128/JVI.01910-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

Review 1.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

Review 2.  Regulation of CXCR4 signaling.

Authors:  John M Busillo; Jeffrey L Benovic
Journal:  Biochim Biophys Acta       Date:  2006-11-10

Review 3.  Experimental approaches to the study of HIV-1 latency.

Authors:  Yefei Han; Megan Wind-Rotolo; Hung-Chih Yang; Janet D Siliciano; Robert F Siliciano
Journal:  Nat Rev Microbiol       Date:  2007-02       Impact factor: 60.633

4.  Immediate activation fails to rescue efficient human immunodeficiency virus replication in quiescent CD4+ T cells.

Authors:  Dimitrios N Vatakis; Gregory Bristol; Thomas A Wilkinson; Samson A Chow; Jerome A Zack
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

5.  HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration.

Authors:  Luis M Agosto; Jianqing J Yu; Jihong Dai; Rachel Kaletsky; Daphne Monie; Una O'Doherty
Journal:  Virology       Date:  2007-07-13       Impact factor: 3.616

6.  Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

Authors:  Angélique Biancotto; Jean-Charles Grivel; Sarah J Iglehart; Christophe Vanpouille; Andrea Lisco; Scott F Sieg; Robert Debernardo; Kristen Garate; Benigno Rodriguez; Leonid B Margolis; Michael M Lederman
Journal:  Blood       Date:  2007-02-08       Impact factor: 22.113

7.  Addition of deoxynucleosides enhances human immunodeficiency virus type 1 integration and 2LTR formation in resting CD4+ T cells.

Authors:  Gabriela Plesa; Jihong Dai; Cliff Baytop; James L Riley; Carl H June; Una O'Doherty
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

8.  Induction of the Galpha(q) signaling cascade by the human immunodeficiency virus envelope is required for virus entry.

Authors:  Brooke Harmon; Lee Ratner
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

9.  A sensitive, quantitative assay for human immunodeficiency virus type 1 integration.

Authors:  Una O'Doherty; William J Swiggard; Deepa Jeyakumar; David McGain; Michael H Malim
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.

Authors:  Florian Hladik; Polachai Sakchalathorn; Lamar Ballweber; Gretchen Lentz; Michael Fialkow; David Eschenbach; M Juliana McElrath
Journal:  Immunity       Date:  2007-02       Impact factor: 31.745

View more
  61 in total

1.  In vitro activities of candidate microbicides against cell-associated HIV.

Authors:  Philippe Selhorst; Katrijn Grupping; Thomas Bourlet; Olivier Delézay; Kevin K Ariën; Guido Vanham
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

2.  Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection.

Authors:  Nancie M Archin; Naveen K Vaidya; Joann D Kuruc; Abigail L Liberty; Ann Wiegand; Mary F Kearney; Myron S Cohen; John M Coffin; Ronald J Bosch; Cynthia L Gay; Joseph J Eron; David M Margolis; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 3.  HIV reservoirs and latency models.

Authors:  Matthew J Pace; Luis Agosto; Erin H Graf; Una O'Doherty
Journal:  Virology       Date:  2011-02-01       Impact factor: 3.616

4.  HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal.

Authors:  Michael A Moso; Jenny L Anderson; Samantha Adikari; Lachlan R Gray; Georges Khoury; Judy J Chang; Jonathan C Jacobson; Anne M Ellett; Wan-Jung Cheng; Suha Saleh; John J Zaunders; Damian F J Purcell; Paul U Cameron; Melissa J Churchill; Sharon R Lewin; Hao K Lu
Journal:  AIDS       Date:  2019-02-01       Impact factor: 4.177

Review 5.  Therapy for persistent HIV.

Authors:  Kara S Keedy; David M Margolis
Journal:  Trends Pharmacol Sci       Date:  2010-03-05       Impact factor: 14.819

6.  Genetic Evidence That Naive T Cells Can Contribute Significantly to the Human Immunodeficiency Virus Intact Reservoir: Time to Re-evaluate Their Role.

Authors:  Emmanuele Venanzi Rullo; LaMont Cannon; Marilia Rita Pinzone; Manuela Ceccarelli; Giuseppe Nunnari; Una O'Doherty
Journal:  Clin Infect Dis       Date:  2019-11-27       Impact factor: 9.079

7.  SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells.

Authors:  Hanna-Mari Baldauf; Xiaoyu Pan; Elina Erikson; Sarah Schmidt; Waaqo Daddacha; Manja Burggraf; Kristina Schenkova; Ina Ambiel; Guido Wabnitz; Thomas Gramberg; Sylvia Panitz; Egbert Flory; Nathaniel R Landau; Serkan Sertel; Frank Rutsch; Felix Lasitschka; Baek Kim; Renate König; Oliver T Fackler; Oliver T Keppler
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

8.  CD4+ memory stem cells are infected by HIV-1 in a manner regulated in part by SAMHD1 expression.

Authors:  Caroline O Tabler; Mark B Lucera; Aiman A Haqqani; David J McDonald; Stephen A Migueles; Mark Connors; John C Tilton
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

9.  Efficient delivery of lentiviral vectors into resting human CD4 T cells.

Authors:  X Geng; G Doitsh; Z Yang; N L K Galloway; W C Greene
Journal:  Gene Ther       Date:  2014-02-27       Impact factor: 5.250

10.  Cellular restriction targeting viral capsids perturbs human immunodeficiency virus type 1 infection of nondividing cells.

Authors:  Masahiro Yamashita; Michael Emerman
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.